Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Schuster

Showing results (451-460 of 630) with videos related to

Pageof 63
Sort By:
Cancers|October 16, 2024
Prevalence and Prognostication of CD5+ Mature T-Cell LymphomasOmar Elghawy, Miao Cao, Jason Xu, et al.
Blood Advances|August 30, 2024
Local radiation enhances systemic CAR T-cell efficacy by augmenting antigen crosspresentation and T-cell infiltrationNektarios Kostopoulos, Francesca Costabile, Elisavet Krimitza, et al.
Transplantation and Cellular Therapy|January 23, 2025
Prolonged Neurologic Symptoms Following Immune Effector Cell-Associated Neurotoxicity Syndrome in Patients With Large B-cell Lymphoma Treated With Chimeric Antigen Receptor-Modified T Cell TherapyLuke Maillie, Sunita D Nasta, Jakub Svoboda, et al.
American Journal of Hematology|March 26, 2016
Autologous stem cell transplantation in first complete remission may not extend progression-free survival in patients with peripheral T cell lymphomasClinton Yam, Daniel J Landsburg, Kevin T Nead, et al.
Blood Neoplasia|January 15, 2026
Tisagenlecleucel in combination with ibrutinib in adults with relapsed and/or refractory large B-cell lymphomasJulio C Chavez, Ellen Napier, Attilio Bondanza, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 20, 2015
The Impact of EBV Status on Characteristics and Outcomes of Posttransplantation Lymphoproliferative DisorderM R Luskin, D S Heil, K S Tan, et al.
Blood Cancer Discovery|June 27, 2025
DLBCL cells emerge post CD19 CAR-T with cross-antigen resistance and a gene signature predictive of clinical CAR-T responseFabiana Lϋӧnd, Jeanne Whalen, Youngchul Song, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|August 19, 2007
Association between elevated whole blood Epstein-Barr virus (EBV)-encoded RNA EBV polymerase chain reaction and reduced incidence of acute lung allograft rejectionVivek N Ahya, Lisa P Douglas, Charalambos Andreadis, et al.
Health Science Reports|May 27, 2022
Risk factors for spontaneous preterm birth among healthy nulliparous pregnant women in the Netherlands, a prospective cohort studyHeleen J Schuster, Myrthe J C S Peelen, Petra J Hajenius, et al.
Clinical Lymphoma|July 3, 2003
Use of ibritumomab tiuxetan anti-CD20 radioimmunotherapy in a non-Hodgkin's lymphoma patient previously treated with a yttrium-90-labeled anti-CD22 monoclonal antibodyDonald E Tsai, Ivan Maillard, Stephen J Schuster, et al.
Pageof 63

Showing results (451-460 of 630) with videos related to

Sort By:
Pageof 63
Cancers|October 16, 2024
Prevalence and Prognostication of CD5+ Mature T-Cell LymphomasOmar Elghawy, Miao Cao, Jason Xu, et al.
Blood Advances|August 30, 2024
Local radiation enhances systemic CAR T-cell efficacy by augmenting antigen crosspresentation and T-cell infiltrationNektarios Kostopoulos, Francesca Costabile, Elisavet Krimitza, et al.
Transplantation and Cellular Therapy|January 23, 2025
Prolonged Neurologic Symptoms Following Immune Effector Cell-Associated Neurotoxicity Syndrome in Patients With Large B-cell Lymphoma Treated With Chimeric Antigen Receptor-Modified T Cell TherapyLuke Maillie, Sunita D Nasta, Jakub Svoboda, et al.
American Journal of Hematology|March 26, 2016
Autologous stem cell transplantation in first complete remission may not extend progression-free survival in patients with peripheral T cell lymphomasClinton Yam, Daniel J Landsburg, Kevin T Nead, et al.
Blood Neoplasia|January 15, 2026
Tisagenlecleucel in combination with ibrutinib in adults with relapsed and/or refractory large B-cell lymphomasJulio C Chavez, Ellen Napier, Attilio Bondanza, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 20, 2015
The Impact of EBV Status on Characteristics and Outcomes of Posttransplantation Lymphoproliferative DisorderM R Luskin, D S Heil, K S Tan, et al.
Blood Cancer Discovery|June 27, 2025
DLBCL cells emerge post CD19 CAR-T with cross-antigen resistance and a gene signature predictive of clinical CAR-T responseFabiana Lϋӧnd, Jeanne Whalen, Youngchul Song, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|August 19, 2007
Association between elevated whole blood Epstein-Barr virus (EBV)-encoded RNA EBV polymerase chain reaction and reduced incidence of acute lung allograft rejectionVivek N Ahya, Lisa P Douglas, Charalambos Andreadis, et al.
Health Science Reports|May 27, 2022
Risk factors for spontaneous preterm birth among healthy nulliparous pregnant women in the Netherlands, a prospective cohort studyHeleen J Schuster, Myrthe J C S Peelen, Petra J Hajenius, et al.
Clinical Lymphoma|July 3, 2003
Use of ibritumomab tiuxetan anti-CD20 radioimmunotherapy in a non-Hodgkin's lymphoma patient previously treated with a yttrium-90-labeled anti-CD22 monoclonal antibodyDonald E Tsai, Ivan Maillard, Stephen J Schuster, et al.
Pageof 63